Most Recent

image: Erica Larschan: Hitting Her Targets

Erica Larschan: Hitting Her Targets

By | November 1, 2012

Assistant Professor, Molecular Biology, Cell Biology, & Biochemistry Brown University, Age: 36

1 Comment

image: Omega-3s: Fishing for a Mechanism

Omega-3s: Fishing for a Mechanism

By | November 1, 2012

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.

4 Comments

image: The Road Less Traveled

The Road Less Traveled

By | November 1, 2012

First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Exit Strategy

Exit Strategy

By | November 1, 2012

Large RNA-protein packets use a novel mechanism to escape the cell nucleus.

0 Comments

image: Long and Rocky Roads

Long and Rocky Roads

By | November 1, 2012

From basic research to beneficial therapies

0 Comments

image: Metabolomics Sheds Light on TB Drug

Metabolomics Sheds Light on TB Drug

By | November 1, 2012

Understanding the mechanism of a classic tuberculosis treatment could refine future strategies for TB drug development.

1 Comment

image: A Window into Cancer

A Window into Cancer

By | October 31, 2012

Researchers implant a glass pane in the abdominal walls of living mice to watch cancer cells metastasize to the liver.

2 Comments

image: Fair Flu Viruses Closely Matched

Fair Flu Viruses Closely Matched

By | October 30, 2012

A study finds that the genomes of swine and human flu viruses associated with a county fair in Ohio are almost perfectly matched, suggesting interspecies transmission.

0 Comments

image: mRNA Not Equal in All Cells

mRNA Not Equal in All Cells

By | October 26, 2012

Scientists identify a false assumption of standard gene expression analyses that could lead to the reappraisal of many prior studies.

5 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech